申请人:BASF Aktiengesellschaft
公开号:US04389403A1
公开(公告)日:1983-06-21
1-Aroyl-2-phenylamino-2-imidazolines of the general formula ##STR1## where R.sup.1 and R.sup.2 are identical or different and each is chlorine, bromine, fluorine, methyl, ethyl, methoxy, trifluoromethyl or cyano, R.sup.3 has the meanings given for R.sup.1 and R.sup.2 or is hydrogen and Ar is an unsubstituted or substituted monocyclic or bicyclic heteroaromatic radical containing 1, 2 or 3 nitrogen and/or oxygen and/or sulfur atoms, their salts with physiologically tolerated acids, their preparation, and drugs containing these compounds. The compounds have, inter alia, a blood pressure-reducing action.
通式为##STR1##的1-Aroyl-2-phenylamino-2-imidazolines,其中R.sup.1和R.sup.2相同或不同,且每个都是氯、溴、氟、甲基、乙基、甲氧基、三氟甲基或氰基,R.sup.3具有R.sup.1和R.sup.2所给出的含义或为氢,Ar为未取代或取代的含有1、2或3个氮和/或氧和/或硫原子的单环或双环杂芳基基团,其与生理耐受酸的盐,其制备以及含有这些化合物的药物。这些化合物具有降低血压的作用。